These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7102532)

  • 1. Pindolol and systolic time intervals in patients with hypertension.
    Hammond JJ; Kirkendall WM; Jacks-Nagle VL; Plotnick GD; Fisher ML; Hamilton JH; Robinson M; Carliner NH; Janoski AH; Hamilton BP
    Am Heart J; 1982 Aug; 104(2 Pt 2):456-64. PubMed ID: 7102532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pindolol and propranolol in patients with angina pectoris and normal or near-normal ventricular function. Lack of influence of intrinsic sympathomimetic activity on global and segmental left ventricular function assessed by radionuclide ventriculography.
    Manyari DE; Kostuk WJ; Carruthers SG; Johnston DJ; Purves P
    Am J Cardiol; 1983 Feb; 51(3):427-33. PubMed ID: 6401908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial measurements of systolic time intervals during treatment with hydrochlorothiazide alone and combined with other antihypertensive agents.
    Kyle MC; Freis ED
    Am J Cardiol; 1985 Jan; 55(1):107-11. PubMed ID: 3966370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary function in hypertensive patients treated with pindolol: a report of two studies.
    Hamilton BP; Hamilton J; Kirkendall WM
    Am Heart J; 1982 Aug; 104(2 Pt 2):432-7. PubMed ID: 7048880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in wall motion after pindolol: a mechanism for the preservation of left ventricular function in coronary artery disease.
    Manfroi WC; Vieira SR; Koppe VF; Goldin JR; Freitas FM; Faraco EZ; Ribeiro JP
    Braz J Med Biol Res; 1989; 22(7):825-31. PubMed ID: 2698244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the effects of beta-blockers with and without intrinsic sympathomimetic activity on hemodynamics and left ventricular function at rest and during exercise in patients with coronary artery disease.
    Choong CY; Roubin GS; Harris PJ; Tokuyasu Y; Shen WF; Bautovich GJ; Kelly DT
    J Cardiovasc Pharmacol; 1986; 8(3):441-8. PubMed ID: 2425156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of intrinsic sympathomimetic activity on regional left ventricular function; use of regional ejection fraction to demonstrate a beneficial action by pindolol over propranolol on hypokinetic segments.
    Johnston DL; Manyari DE; Kostuk WJ
    Can J Cardiol; 1985; 1(3):174-9. PubMed ID: 2996726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum levels of beta-methyldigoxin and contractile efficiency of the myocardium evaluated with systolic polygraphy and determination of cardiac output].
    Pelosi G; Bracchi G; Orazio S; Cereda A
    Minerva Med; 1981 Feb; 72(4-5):225-31. PubMed ID: 7010220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systolic time intervals as possible predictors of pressure response to sustained beta-adrenergic blockade in arterial hypertension. A within-patient, placebo-controlled study.
    Verdecchia P; Brignole M; Delfino G; Queirolo C; De Marchi G; Bertulla A
    Hypertension; 1983; 5(1):140-6. PubMed ID: 6336719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pindolol: effects on blood pressure and plasma renin activity.
    Glassock RJ; Weitzman RE; Bennett CM; Maxwell M; Hamilton B; Winer N; Kirkendall W; Gonasun L
    Am Heart J; 1982 Aug; 104(2 Pt 2):421-5. PubMed ID: 7048878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute hemodynamic effects of pindolol and propranolol in patients with dilated cardiomyopathy: relevance of intrinsic sympathomimetic activity.
    Shanes JG; Wolfkiel C; Ghali J; Dierenfeldt BJ; Kondos GT; Bauman JL
    Am Heart J; 1988 Nov; 116(5 Pt 1):1268-75. PubMed ID: 3189143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of propranolol and atenolol on plasma renin activity and systolic time intervals in borderline hypertension.
    González-Gómez A; García-Barreto D; Gamio Capestany F; Hernández-Cañero A; Fong Chi S
    Cor Vasa; 1982; 24(6):422-8. PubMed ID: 6764167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial measurements of systolic time intervals: effects of propranolol alone and combined with other agents in hypertensive patients.
    Kyle MC; Freis ED
    Hypertension; 1980; 2(1):111-7. PubMed ID: 7372352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the subacute hemodynamic effects of atenolol, propranolol, pindolol, and nebivolol.
    De Crée J; Cobo C; Geukens H; Verhaegen H
    Angiology; 1990 Feb; 41(2):95-105. PubMed ID: 1968323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sympathetic hyperreflexia in tetraplegics. The value of systolic time intervals in assessing drug effects.
    Sommers DK
    S Afr Med J; 1980 Dec; 58(24):978-80. PubMed ID: 7444702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of beta blockade and intrinsic sympathomimetic activity on hemodynamics, inotropy and respiration at rest and during exercise.
    Sundberg S; Gordin A
    Am J Cardiol; 1986 Jun; 57(15):1394-9. PubMed ID: 2872795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Systolic time intervals in essential hypertension. II. Variations produced by treatment with labetalol].
    Rossi A; Ziacchi V; Lomanto B
    Arch Mal Coeur Vaiss; 1979 Nov; 72(11):1240-6. PubMed ID: 121529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preservation of the end-systolic pressure/end-systolic dimension relation following pindolol in congestive heart failure.
    Binkley PF; Lewe RF; Unverferth DV; Leier CV
    Am Heart J; 1988 Jun; 115(6):1245-50. PubMed ID: 3376842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of hypertension with the beta-receptor-antagonist pindolol (Viskèn). A comparison with chlorthalidone (Hygroton)].
    Schaffalitzky de Muckadel ; Gyntelberg F
    Ugeskr Laeger; 1973 May; 135(20):971-4. PubMed ID: 4585570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.